-
Shining the
on #JLABSSD alumni@MiratiTx, who's experimental drug may have the potential to significantly reduce tumor size for patients with advanced lung & colorectal cancer. In a small, early-stage trial, 40% of patients saw a reduction in tumor size.https://jlabs.tv/2u2NpoR -
Congratulations to Joe Payne, Pad Chivukula @ArctusrusRX
#JLABSSD alumni for the expansion of its licensing deal for further discovery & development of therapeutics for 12 rare-disease targets. Read more: http://jlabs.buzz/r6x -
Things are heating up for
@ArcturusRX#JLABSSD alumni company, who announced an expansion to their research collaboration to develop#MRNA#DNA and#siRNA#therapeutics for 12 rare disease targets. Read more:https://hubs.ly/H0jt2db0
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.